USCAP Annual Meeting 2024

Calling all Pathologists

Do you want to learn more about how AI diagnostics, leveraging routine digital HES images, can integrate seamlessly into your digital pathology workflow?

‍

Visit the Owkin booth for a demo of:

MSIntuit® CRC, the first CE-marked AI diagnostic that pre-screens for MSI, a key biomarker used in the management of patients with colorectal cancer.

And RlapsRisk® BC, our AI diagnostic that helps assess the risk of relapse of early breast cancer patients.

‍

Don’t miss our presentations:

Monday, March 25

Oral presentation: MSI CRC Through the Lens of AI - Overlooked Morphological and Clinical Features, 9:15 - 9:30 am EST,

Katharina von Loga, Head of Pathology, Owkin 

‍

Tuesday, March 26

Poster presentation: How Ready Is Your AI for Clinical Routine: Assessing Model Robustness to Sample Preparation and Digitization‍

Poster Board #193, 9:30 AM - 12:00 PM EST

Damien Jacobs, Senior Clinical Biostatistician, Owkin

‍

Wednesday, March 27

Poster presentation: AI-based Optimization of MSI Testing Using H&E Histology Slides of Colorectal Cancer Biopsies‍

Poster Board #65, 1:00 PM - 4:30 PM EST

Arnaud Fouillet, Senior Product Manager, Owkin

‍

Meet our team

• Michael Auffret, SVP Diagnostic Products and Regulatory, Owkin
• Rodney Hawkins, Head of US Product and Business Development, Owkin
• Katharina von Loga, Head of Pathology, Owkin
• Greg Taylor, VP Global Commercial Diagnostics, Owkin
• ‍Arnaud Fouillet, Sr. Product Manager, Owkin